Align Technology, Inc. (ALGN)
USD 154.24
(-5.94%)
USD 154.24
(-5.94%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | 643.33 Million USD | 2.29% |
| 2022 | 642.59 Million USD | -34.19% |
| 2021 | 976.4 Million USD | 232.52% |
| 2020 | 293.63 Million USD | -27.94% |
| 2019 | 407.48 Million USD | -12.66% |
| 2018 | 466.56 Million USD | 31.94% |
| 2017 | 353.61 Million USD | 42.06% |
| 2016 | 248.92 Million USD | 31.96% |
| 2015 | 188.63 Million USD | -2.55% |
| 2014 | 193.57 Million USD | 105.47% |
| 2013 | 94.21 Million USD | 10.07% |
| 2012 | 85.59 Million USD | -5.28% |
| 2011 | 90.36 Million USD | -12.04% |
| 2010 | 102.73 Million USD | 402.05% |
| 2009 | -34.01 Million USD | -319.23% |
| 2008 | 15.51 Million USD | -54.18% |
| 2007 | 33.85 Million USD | 190.19% |
| 2006 | -37.53 Million USD | -1634.59% |
| 2005 | 2.44 Million USD | -74.95% |
| 2004 | 9.76 Million USD | 148.98% |
| 2003 | -19.93 Million USD | 70.78% |
| 2002 | -68.23 Million USD | 30.97% |
| 2001 | -98.84 Million USD | -21.86% |
| 2000 | -81.11 Million USD | -451.62% |
| 1999 | -14.7 Million USD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q1 | 154.13 Million USD | -16.92% |
| 2024 Q3 | 131.17 Million USD | -8.91% |
| 2024 Q2 | 178.17 Million USD | 15.6% |
| 2023 Q4 | 185.53 Million USD | 11.53% |
| 2023 Q1 | 97.69 Million USD | -13.28% |
| 2023 Q2 | 171.93 Million USD | 75.99% |
| 2023 Q3 | 166.34 Million USD | -3.25% |
| 2023 FY | 657.32 Million USD | 2.29% |
| 2022 Q3 | 111.46 Million USD | -40.77% |
| 2022 FY | 642.59 Million USD | -34.19% |
| 2022 Q4 | 112.66 Million USD | 1.07% |
| 2022 Q2 | 188.19 Million USD | 0.02% |
| 2022 Q1 | 188.16 Million USD | -14.82% |
| 2021 Q3 | 261.16 Million USD | -2.88% |
| 2021 Q4 | 220.89 Million USD | -15.42% |
| 2021 Q2 | 268.9 Million USD | 19.28% |
| 2021 Q1 | 225.44 Million USD | 5.75% |
| 2021 FY | 976.4 Million USD | 232.52% |
| 2020 FY | 293.63 Million USD | -27.94% |
| 2020 Q4 | 213.18 Million USD | 20.4% |
| 2020 Q2 | -73 Million USD | -204.41% |
| 2020 Q1 | 69.91 Million USD | -53.74% |
| 2020 Q3 | 177.06 Million USD | 342.56% |
| 2019 Q2 | 176.49 Million USD | 101.24% |
| 2019 Q1 | 87.7 Million USD | -27.2% |
| 2019 Q3 | 127.15 Million USD | -27.96% |
| 2019 Q4 | 151.15 Million USD | 18.87% |
| 2019 FY | 407.48 Million USD | -12.66% |
| 2018 Q1 | 98.19 Million USD | -10.41% |
| 2018 FY | 466.56 Million USD | 31.94% |
| 2018 Q2 | 122.69 Million USD | 24.95% |
| 2018 Q3 | 125.2 Million USD | 2.05% |
| 2018 Q4 | 120.47 Million USD | -3.78% |
| 2017 Q1 | 61.67 Million USD | -9.8% |
| 2017 FY | 353.61 Million USD | 42.06% |
| 2017 Q2 | 83.56 Million USD | 35.5% |
| 2017 Q3 | 98.76 Million USD | 18.18% |
| 2017 Q4 | 109.6 Million USD | 10.98% |
| 2016 Q2 | 65.13 Million USD | 22.13% |
| 2016 FY | 248.92 Million USD | 31.96% |
| 2016 Q4 | 68.37 Million USD | 10.14% |
| 2016 Q3 | 62.07 Million USD | -4.69% |
| 2016 Q1 | 53.33 Million USD | -10.12% |
| 2015 Q4 | 59.33 Million USD | 55.97% |
| 2015 FY | 188.63 Million USD | -2.55% |
| 2015 Q1 | 48.92 Million USD | -4.99% |
| 2015 Q2 | 42.32 Million USD | -13.49% |
| 2015 Q3 | 38.04 Million USD | -10.11% |
| 2014 FY | 193.57 Million USD | 105.47% |
| 2014 Q2 | 48.73 Million USD | 16.57% |
| 2014 Q1 | 41.8 Million USD | -21.01% |
| 2014 Q3 | 51.54 Million USD | 5.78% |
| 2014 Q4 | 51.49 Million USD | -0.1% |
| 2013 Q3 | 41.46 Million USD | 9.4% |
| 2013 Q1 | -38.07 Million USD | -323.04% |
| 2013 FY | 94.21 Million USD | 10.07% |
| 2013 Q4 | 52.92 Million USD | 27.63% |
| 2013 Q2 | 37.9 Million USD | 199.54% |
| 2012 Q3 | 29.16 Million USD | -19.0% |
| 2012 Q4 | 17.07 Million USD | -41.47% |
| 2012 Q1 | 28 Million USD | 5.96% |
| 2012 FY | 85.59 Million USD | -5.28% |
| 2012 Q2 | 36.01 Million USD | 28.59% |
| 2011 FY | 90.36 Million USD | -12.04% |
| 2011 Q1 | 21.02 Million USD | 42.34% |
| 2011 Q2 | 16.59 Million USD | -21.06% |
| 2011 Q3 | 26.31 Million USD | 58.55% |
| 2011 Q4 | 26.43 Million USD | 0.45% |
| 2010 Q4 | 14.77 Million USD | -32.63% |
| 2010 FY | 102.73 Million USD | 402.05% |
| 2010 Q2 | 45.34 Million USD | 119.08% |
| 2010 Q1 | 20.69 Million USD | 41.32% |
| 2010 Q3 | 21.92 Million USD | -51.65% |
| 2009 Q2 | 6.25 Million USD | 18.34% |
| 2009 FY | -34.01 Million USD | -319.23% |
| 2009 Q3 | -60.19 Million USD | -1062.64% |
| 2009 Q4 | 14.64 Million USD | 124.33% |
| 2009 Q1 | 5.28 Million USD | 298.79% |
| 2008 Q4 | 1.32 Million USD | -76.72% |
| 2008 FY | 15.51 Million USD | -54.18% |
| 2008 Q3 | 5.69 Million USD | 46.98% |
| 2008 Q2 | 3.87 Million USD | -16.3% |
| 2008 Q1 | 4.62 Million USD | -7.7% |
| 2007 Q1 | 7 Million USD | 138.74% |
| 2007 Q2 | 13.44 Million USD | 92.11% |
| 2007 Q3 | 8.39 Million USD | -37.57% |
| 2007 FY | 33.85 Million USD | 190.19% |
| 2007 Q4 | 5.01 Million USD | -40.3% |
| 2006 Q4 | -18.06 Million USD | -64.77% |
| 2006 FY | -37.53 Million USD | -1634.59% |
| 2006 Q3 | -10.96 Million USD | -233.18% |
| 2006 Q1 | -5.21 Million USD | -886.27% |
| 2006 Q2 | -3.29 Million USD | 36.87% |
| 2005 FY | 2.44 Million USD | -74.95% |
| 2005 Q1 | 2.12 Million USD | 224.54% |
| 2005 Q2 | 1.19 Million USD | -43.96% |
| 2005 Q4 | 663 Thousand USD | 143.08% |
| 2005 Q3 | -1.53 Million USD | -229.0% |
| 2004 FY | 9.76 Million USD | 148.98% |
| 2004 Q1 | 917 Thousand USD | 95.11% |
| 2004 Q2 | 4.34 Million USD | 373.39% |
| 2004 Q3 | 3.85 Million USD | -11.29% |
| 2004 Q4 | 656 Thousand USD | -82.97% |
| 2003 FY | -19.93 Million USD | 70.78% |
| 2003 Q2 | -8.18 Million USD | 4.64% |
| 2003 Q4 | 470 Thousand USD | 126.89% |
| 2003 Q1 | -8.58 Million USD | 39.4% |
| 2003 Q3 | -1.74 Million USD | 78.65% |
| 2002 Q1 | -18.79 Million USD | 9.74% |
| 2002 FY | -68.23 Million USD | 30.97% |
| 2002 Q4 | -14.16 Million USD | 15.29% |
| 2002 Q3 | -16.72 Million USD | 9.87% |
| 2002 Q2 | -18.55 Million USD | 1.31% |
| 2001 Q2 | -23.56 Million USD | 25.01% |
| 2001 Q1 | -31.42 Million USD | 0.0% |
| 2001 FY | -98.84 Million USD | -21.86% |
| 2001 Q4 | -20.82 Million USD | 9.55% |
| 2001 Q3 | -23.02 Million USD | 2.3% |
| 2000 FY | -81.11 Million USD | -451.62% |
| 2000 Q1 | -8.04 Million USD | 0.0% |
| 1999 FY | -14.7 Million USD | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Acutus Medical, Inc. | -14.36 Million USD | 4579.758% |
| Cerus Corporation | -30.05 Million USD | 2240.678% |
| OrthoPediatrics Corp. | -25.76 Million USD | 2596.849% |
| PetVivo Holdings, Inc. | -10.62 Million USD | 6157.032% |
| Talis Biomedical Corporation | -66.81 Million USD | 1062.865% |
| Vivos Therapeutics, Inc. | -17.29 Million USD | 3819.577% |
| Inogen, Inc. | -109.38 Million USD | 688.136% |
| Spectral AI, Inc. | -12.98 Million USD | 5054.852% |
| Nano-X Imaging Ltd. | -62.58 Million USD | 1127.877% |
| CVRx, Inc. | -43.1 Million USD | 1592.56% |
| DIH Holding US, Inc. Warrants | -3.52 Million USD | 18335.204% |
| Helius Medical Technologies, Inc. | -12.42 Million USD | 5276.521% |
| Orthofix Medical Inc. | -139.11 Million USD | 562.467% |
| Venus Concept Inc. | -28.3 Million USD | 2372.556% |
| Accelerate Diagnostics, Inc. | -54.02 Million USD | 1290.749% |
| Bioventus Inc. | -81.72 Million USD | 887.199% |
| BrainsWay Ltd. | -4.92 Million USD | 13157.398% |
| Envoy Medical, Inc. | -18.37 Million USD | 3601.922% |
| electroCore, Inc. | -18.8 Million USD | 3521.101% |
| IceCure Medical Ltd | -15.57 Million USD | 4230.316% |
| Lucid Diagnostics Inc. | -48.48 Million USD | 1426.963% |
| Monogram Orthopaedics, Inc. | -17.26 Million USD | 3825.602% |
| MaxCyte, Inc. | -48.29 Million USD | 1431.99% |
| NeuroOne Medical Technologies Corporation | -11.95 Million USD | 5481.217% |
| Nexalin Technology, Inc. | -5.69 Million USD | 11393.971% |
| PAVmed Inc | -68.79 Million USD | 1035.152% |
| Rapid Micro Biosystems, Inc. | -56.56 Million USD | 1237.383% |
| RxSight, Inc. | -50.08 Million USD | 1384.492% |
| Sight Sciences, Inc. | -57.27 Million USD | 1223.264% |
| SI-BONE, Inc. | -46.93 Million USD | 1470.817% |
| TELA Bio, Inc. | -44.07 Million USD | 1559.644% |
| TriSalus Life Sciences, Inc. | -54.15 Million USD | 1288.066% |
| Treace Medical Concepts, Inc. | -51.42 Million USD | 1350.949% |
| LivaNova PLC | -68.49 Million USD | 1039.207% |
| 908 Devices Inc. | -42.75 Million USD | 1604.603% |
| Alphatec Holdings, Inc. | -173.39 Million USD | 471.025% |
| Nemaura Medical Inc. | -9.59 Million USD | 6804.766% |
| NeuroPace, Inc. | -27.17 Million USD | 2467.476% |
| LENSAR, Inc. | -12.22 Million USD | 5360.757% |
| Apyx Medical Corporation | -17.25 Million USD | 3827.551% |
| Cutera, Inc. | -156.23 Million USD | 511.789% |
| STRATA Skin Sciences, Inc. | -8.6 Million USD | 7577.197% |
| BioSig Technologies, Inc. | -28.51 Million USD | 2356.376% |
| Anika Therapeutics, Inc. | -87.63 Million USD | 834.077% |
| ClearPoint Neuro, Inc. | -22.44 Million USD | 2966.159% |
| Integra LifeSciences Holdings Corporation | 111.52 Million USD | -476.85% |
| Axonics, Inc. | -26.05 Million USD | 2568.964% |
| Outset Medical, Inc. | -169.77 Million USD | 478.947% |
| IRIDEX Corporation | -10 Million USD | 6528.88% |
| PROCEPT BioRobotics Corporation | -109.17 Million USD | 689.299% |
| IRadimed Corporation | 20.03 Million USD | -3110.997% |
| Tivic Health Systems, Inc. | -8.24 Million USD | 7902.766% |
| INVO Bioscience, Inc. | -6.76 Million USD | 9606.772% |
| Telesis Bio, Inc. | -35.15 Million USD | 1930.265% |
| Viemed Healthcare, Inc. | 14.33 Million USD | -4389.449% |
| Varex Imaging Corporation | 32.1 Million USD | -1904.168% |
| Quipt Home Medical Corp. | 3.91 Million USD | -16315.871% |
| Inspira Technologies Oxy B.H.N. Ltd. | -12.13 Million USD | 5402.382% |
| Pulmonx Corporation | -61.93 Million USD | 1138.731% |
| Dynatronics Corporation | -2.27 Million USD | 28402.878% |
| Modular Medical, Inc. | -17.52 Million USD | 3770.135% |
| ReShape Lifesciences Inc. | -14.63 Million USD | 4494.685% |
| Semler Scientific, Inc. | 22.25 Million USD | -2790.627% |
| InMode Ltd. | 195.66 Million USD | -228.804% |
| Bruker Corporation | 436.9 Million USD | -47.251% |
| Cytosorbents Corporation | -31.2 Million USD | 2161.369% |
| DexCom, Inc. | 597.7 Million USD | -7.636% |
| Viveve Medical, Inc. | -21.55 Million USD | 3084.912% |
| ZimVie Inc. | -30.93 Million USD | 2179.376% |
| Movano Inc. | -29.69 Million USD | 2266.851% |
| Cytek Biosciences, Inc. | -27.84 Million USD | 2410.426% |
| Nexalin Technology, Inc. | -5.69 Million USD | 11393.971% |
| DIH Holdings US, Inc. Class A Common Stock | -3.52 Million USD | 18335.204% |
| Tandem Diabetes Care, Inc. | -233.23 Million USD | 375.838% |
| Profound Medical Corp. | -28.61 Million USD | 2348.176% |
| Insulet Corporation | 220 Million USD | -192.426% |
| enVVeno Medical Corporation | -25.23 Million USD | 2649.085% |
| Surmodics, Inc. | -5.64 Million USD | 11496.599% |
| iCAD, Inc. | -7.68 Million USD | 8466.992% |
| Nuwellis, Inc. | -17.63 Million USD | 3749.109% |
| Biotricity, Inc. | -8.82 Million USD | 7387.25% |
| iRhythm Technologies, Inc. | -125.16 Million USD | 614.008% |
| Aethlon Medical, Inc. | -12.63 Million USD | 5191.082% |
| InspireMD, Inc. | -21.14 Million USD | 3142.794% |
| PAVmed Inc. | -68.79 Million USD | 1035.152% |
| BIOLASE, Inc. | -17.93 Million USD | 3686.653% |
| Beyond Air, Inc. | -63 Million USD | 1121.074% |
| FONAR Corporation | 16.53 Million USD | -3790.679% |
| AxoGen, Inc. | -21.46 Million USD | 3097.568% |
| Vivani Medical, Inc. | -26.96 Million USD | 2485.826% |
| Tactile Systems Technology, Inc. | 18.04 Million USD | -3465.977% |
| Inari Medical, Inc. | -14.03 Million USD | 4684.792% |
| UFP Technologies, Inc. | 57.66 Million USD | -1015.667% |
| QT Imaging Holdings, Inc. | -4.92 Million USD | 13155.808% |
| Heart Test Laboratories, Inc. | -6.3 Million USD | 10302.37% |
| Tenon Medical, Inc. | -15.72 Million USD | 4190.659% |
| Autonomix Medical, Inc. Common Stock | -7.47 Million USD | 8707.68% |
| Co-Diagnostics, Inc. | -42.7 Million USD | 1606.426% |
| AdaptHealth Corp. | -598.4 Million USD | 207.51% |
| Sintx Technologies, Inc. | -13.35 Million USD | 4916.125% |
| NanoVibronix, Inc. | -3.43 Million USD | 18823.458% |
| Quanterix Corporation | -49.7 Million USD | 1394.417% |
| Inspira Technologies Oxy B.H.N. Ltd. | -12.13 Million USD | 5402.382% |
| Sensus Healthcare, Inc. | -382 Thousand USD | 168513.089% |
| Pacific Biosciences of California, Inc. | -334.46 Million USD | 292.347% |
| TransMedics Group, Inc. | -28.72 Million USD | 2339.489% |
| ReWalk Robotics Ltd. | -23.61 Million USD | 2824.623% |
| NeuroMetrix, Inc. | -7.15 Million USD | 9095.821% |
| Hyperfine, Inc. | -48.11 Million USD | 1437.084% |
| Establishment Labs Holdings Inc. | -65.02 Million USD | 1089.355% |
| Biomerica, Inc. | -6.36 Million USD | 10204.256% |
| Bone Biologics Corporation | -9.42 Million USD | 6923.476% |
| AVITA Medical, Inc. | -40.4 Million USD | 1692.338% |
| Bluejay Diagnostics, Inc. | -10.31 Million USD | 6339.206% |
| Silk Road Medical, Inc | -59.27 Million USD | 1185.418% |